Dr Hogarth uses an international comparative methodology to explore the continued salience of national institutions such as regulatory regimes and healthcare systems, in a bioeconomy which is increasingly characterised by global governance structures, international scientific collaborations and transnational flows of capital and scientific labour.
His work is situated at the interface of science and technology studies, medical sociology, history of medicine, bioethics, innovation studies and regulatory studies and involves interdisciplinary collaboration with scholars across the domains of biomedicine, law, politics and public health. He has long-standing collaborative links with Dr Kathy Liddell, Director of the Centre for Law, Medicine and Life Sciences at Faculty of Law Cambridge.
His work combines empirical research with normative analysis of public policy and commercial strategy. He has produced policy reports for the European Commission and Health Canada, and in the UK Human Genetics Commission. He was a member of the Department of Health's Emerging Science and Bioethics Advisory Committee from 2012-14, and currently serves on an external strategy group advising the Medicines and Healthcare Products Regulatory Agency's on the revision of the EU regulations for diagnostic devices.
